Obesity and obstructive sleep apnea.

There is a very high prevalence of OSA in obese individuals and a high prevalence of obesity in patients with OSA. The pathophysiology of OSA is intimately linked to obesity. Anatomic and functional considerations of the pharyngeal airway, the CNS, central obesity, and leptin likely interact in the development of OSA in obese individuals. OSA may itself predispose individuals to worsening obesity because of sleep deprivation, daytime somnolence, and disrupted metabolism. The diagnosis of OSA requires the clinician's awareness of its potential to cause a spectrum of acute and chronic neurocognitive, psychiatric, and nonspecific symptoms in patients who may be unaware that their sleep is disturbed. Symptoms and examination findings help predict which obese individuals have OSA, and polysomnography is the gold standard by which to make the diagnosis and assess the effects of treatment. Numerous disease states are associated with both OSA and obesity, and it is becoming clear that the relationships are mediated by complex interrelated mechanisms. Common diseases and disease mechanisms in OSA and obesity suggest that conditions related to obesity may be better managed if patients, particularly those who are morbidly obese, are evaluated and treated for previously undiagnosed OSA. OSA is cured in only specific cases with craniofacial or upper airway surgery, and the general application of UVP is not efficacious. OSA also can be cured with sufficient lifestyle-mediated or surgical weight loss; however, in the absence of long-term weight maintenance, OSA returns with weight gain. Although not curative, nasal CPAP is the initial treatment of choice for most patients because of its noninvasive approach and technical efficacy. It is limited, however, by patient acceptance and long-term compliance. Advances in mask comfort and use of humidified air should increase its acceptance. Future management strategies include newer generations of positive airway devices that automatically titrate pressures (which are not yet recommended by expert organizations) and multidisciplinary approaches to managing the care of patients with OSA.

[1]  D. Papanicolaou,et al.  Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. , 2000, The Journal of clinical endocrinology and metabolism.

[2]  F. Nobili,et al.  Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. , 2000, Clinical hemorheology and microcirculation.

[3]  ColinE. Sullivan,et al.  REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.

[4]  Bradley Td Right and left ventricular functional impairment and sleep apnea. , 1992, Clinics in chest medicine.

[5]  K. Nakao,et al.  Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. , 1999, Circulation.

[6]  R. Berry,et al.  The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review. , 2002, Sleep.

[7]  T Douglas Bradley,et al.  Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. , 2003, The New England journal of medicine.

[8]  F. Cirignotta,et al.  Hypersomnia with periodic apneas in acquired micrognathia. A bird-like face syndrome. , 1976, Archives of neurology.

[9]  J. Szalai,et al.  Are history and physical examination a good screening test for sleep apnea? , 1991, Annals of internal medicine.

[10]  M. A. Baak The peripheral sympathetic nervous system in human obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[11]  A. J. Block,et al.  The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. , 1982, Chest.

[12]  D. Bliwise,et al.  Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. , 2000, Obesity research.

[13]  N. Douglas,et al.  Self assessment of daytime sleepiness: patient versus partner. , 1995, Thorax.

[14]  J. Manson,et al.  Snoring and risk of cardiovascular disease in women. , 2000, Journal of the American College of Cardiology.

[15]  C. Bouchard Genetics of human obesity: recent results from linkage studies. , 1997, The Journal of nutrition.

[16]  M. Littner,et al.  Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. , 2002, Sleep.

[17]  Remmers Je,et al.  Pathogenesis of upper airway occlusion during sleep , 1978 .

[18]  P. Lavie,et al.  Sleep apnea syndrome treated by repair of deviated nasal septum. , 1983, Chest.

[19]  C. Guilleminault,et al.  Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. , 1976, Annals of internal medicine.

[20]  D. Hillman,et al.  Mandibular advancement splint: an appliance to treat snoring and obstructive sleep apnea. , 1995, American journal of respiratory and critical care medicine.

[21]  J. Hedner,et al.  Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. , 2000, American journal of respiratory and critical care medicine.

[22]  J. Hartikainen,et al.  The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. , 1998, Clinical physiology.

[23]  S Margetic,et al.  Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.

[24]  D F Kripke,et al.  Periodic limb movements in sleep in community-dwelling elderly. , 1991, Sleep.

[25]  S. Shea,et al.  Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. , 1989, The European respiratory journal.

[26]  R. Elston,et al.  A whole-genome scan for obstructive sleep apnea and obesity. , 2003, American journal of human genetics.

[27]  L J Findley,et al.  Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia. , 1986, Chest.

[28]  C. Iber,et al.  Obstructive sleep apnea associated with adult-acquired micrognathia from rheumatoid arthritis. , 1983, The American review of respiratory disease.

[29]  E. Bixler,et al.  Sleep apnea and sleep disruption in obese patients. , 1994, Archives of internal medicine.

[30]  A. Nissinen,et al.  Familial aggregation of body mass index: a population-based family study in eastern Finland. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[31]  Atul Malhotra,et al.  Obstructive sleep apnoea , 2002, The Lancet.

[32]  G. Parati,et al.  Sleep apnoea and hypertension , 2002, Current opinion in nephrology and hypertension.

[33]  L. Findley,et al.  Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. , 1987, Chest.

[34]  B. Wuyam,et al.  High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. , 1999, European heart journal.

[35]  J. Sorkin,et al.  Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. , 2002, American journal of respiratory and critical care medicine.

[36]  A. Kales,et al.  Severe obstructive sleep apnea--II: Associated psychopathology and psychosocial consequences. , 1985, Journal of chronic diseases.

[37]  A. Thilmann,et al.  Fibrinogen levels and obstructive sleep apnea in ischemic stroke. , 2000, American journal of respiratory and critical care medicine.

[38]  H. Moldofsky,et al.  Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. , 2015, The American review of respiratory disease.

[39]  Tsung O Cheng,et al.  Could elevated C-reactive protein in patients with obstructive sleep apnea be due to obesity per se? , 2003, Circulation.

[40]  R. Wing,et al.  Relationship of a large weight loss to long-term weight change among young and middle-aged US women , 2001, International Journal of Obesity.

[41]  P. Lavie,et al.  Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. , 1992, The American journal of clinical nutrition.

[42]  T. Gislason,et al.  Sleep‐disordered breathing and glucose metabolism in hypertensive men: a population‐based study , 2001, Journal of internal medicine.

[43]  C. Guilleminault,et al.  Blood pressure "dipping" and "non-dipping" in obstructive sleep apnea syndrome patients. , 1996, Sleep.

[44]  N. Sattar,et al.  Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians , 2001, International Journal of Obesity.

[45]  T. Young,et al.  Prospective study of the association between sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.

[46]  P. Vollenweider,et al.  Body fat and sympathetic nerve activity in healthy subjects. , 1994, Circulation.

[47]  J. Hedner,et al.  Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[48]  A. Minenna,et al.  C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women , 2001, International Journal of Obesity.

[49]  C Guilleminault,et al.  A Predictive Morphometric Model for the Obstructive Sleep Apnea Syndrome , 1997, Annals of Internal Medicine.

[50]  C. Guilleminault,et al.  Insulin resistance and sleep-disordered breathing in healthy humans. , 1996, American journal of respiratory and critical care medicine.

[51]  K. Rahmouni,et al.  Leptin and the central neural mechanisms of obesity hypertension. , 2002, Drugs of Today.

[52]  W. Schmidt-Nowara,et al.  Treatment of snoring and obstructive sleep apnea with a dental orthosis. , 1991, Chest.

[53]  C. Sullivan,et al.  Home treatment of obstructive sleep apnoea with continuous positive airway pressure applied through a nose-mask. , 1984, Bulletin europeen de physiopathologie respiratoire.

[54]  T. Rabben,et al.  Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. , 2000, Chest.

[55]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[56]  J. Oppert,et al.  Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. , 2002, Chest.

[57]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[58]  P. L. Smith,et al.  Leptin, obesity, and respiratory function. , 2000, Respiration physiology.

[59]  H. Sugerman,et al.  Gastric surgery for respiratory insufficiency of obesity. , 1986, Chest.

[60]  Arthur S Slutsky,et al.  Do patients with obstructive sleep apnea have thick necks? , 1990, The American review of respiratory disease.

[61]  J. Redman,et al.  Effect of moderate alcohol upon obstructive sleep apnoea. , 2000, The European respiratory journal.

[62]  N. Zamel,et al.  Pharyngeal compliance in snoring subjects with and without obstructive sleep apnea. , 2015, The American review of respiratory disease.

[63]  Terry Young,et al.  Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. , 2002, Archives of internal medicine.

[64]  J S Floras,et al.  Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. , 1998, Journal of applied physiology.

[65]  B. Sanner,et al.  Platelet function in patients with obstructive sleep apnoea syndrome. , 2000, The European respiratory journal.

[66]  F. Sériès,et al.  Utility of Nocturnal Home Oximetry for Case Finding in Patients with Suspected Sleep Apnea Hypopnea Syndrome , 1993, Annals of Internal Medicine.

[67]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[68]  Obstructive sleep apnea caused by hemarthrosis-induced micrognathia. , 1987, European journal of respiratory diseases.

[69]  A. Xie,et al.  Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure , 1991, The Lancet.

[70]  M. Mitler,et al.  Obstructive sleep apnea and body weight. , 1984, Chest.

[71]  D. White,et al.  Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). , 1992, The Journal of clinical investigation.

[72]  D. Hudgel Mechanisms of obstructive sleep apnea. , 1992, Chest.

[73]  P. Lavie,et al.  Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. , 1999, Journal of the American College of Cardiology.

[74]  W. Seeger,et al.  Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. , 2000, American journal of respiratory and critical care medicine.

[75]  P. L. Smith,et al.  Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. , 1983, The American review of respiratory disease.

[76]  J. Laaban,et al.  Pulmonary arterial hypertension in patients with sleep apnoea syndrome , 2000, Thorax.

[77]  J. Peter,et al.  Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. , 1997, Chest.

[78]  J. Hedner,et al.  Therapy with nCPAP: incomplete elimination of Sleep Related Breathing Disorder. , 2000, The European respiratory journal.

[79]  Y. Shapira,et al.  Raised interleukin-6 levels in obese patients. , 2000, Obesity research.

[80]  M. Hans,et al.  Contribution of craniofacial risk factors in increasing apneic activity among obese and nonobese habitual snorers. , 1997, Chest.

[81]  E. Svanborg,et al.  Four‐year follow‐up after uvulopalatopharyngoplasty in 50 unselected patients with obstructive sleep apnea syndrome , 1994, The Laryngoscope.

[82]  K. Franklin,et al.  Sleep apnoea and nocturnal angina , 1995, The Lancet.

[83]  J. Stauffer,et al.  Pharyngeal size and resistance in obstructive sleep apnea. , 1987, The American review of respiratory disease.

[84]  G. Pergola,et al.  Coagulation and fibrinolysis abnormalities in obesity , 2002, Journal of endocrinological investigation.

[85]  T. D. Bradley,et al.  Overnight Shift From Obstructive to Central Apneas in Patients With Heart Failure: Role of Pco2 and Circulatory Delay , 2001, Circulation.

[86]  T. Boxem,et al.  Prevalence and severity of sleep disordered breathing in a group of morbidly obese patients. , 1999 .

[87]  G. Jennings,et al.  Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. , 1997, Circulation.

[88]  V. Hoffstein,et al.  Improvement in upper airway function after weight loss in patients with obstructive sleep apnea. , 1988, The American review of respiratory disease.

[89]  B. Sanner,et al.  Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. , 1997, The European respiratory journal.

[90]  R Colombo,et al.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. , 1999, Circulation.

[91]  A I Pack,et al.  Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. , 1995, American journal of respiratory and critical care medicine.

[92]  D. Kripke,et al.  Prevalent sleep problems in the aged , 1991, Biofeedback and self-regulation.

[93]  J. Stradling,et al.  The efficacy of nasal continuous positive airway pressure in the treatment of obstructive sleep apnea syndrome is proven. , 2000, American journal of respiratory and critical care medicine.

[94]  J. Elwood,et al.  FETAL VIABILITY , 1975, The Lancet.

[95]  A. Malhotra,et al.  The art and science of continuous positive airway pressure therapy in obstructive sleep apnea , 2000, Current opinion in pulmonary medicine.

[96]  D. Pauleit,et al.  Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. , 2002, Chest.

[97]  E. Onal,et al.  Periodic breathing and the pathogenesis of occlusive sleep apneas. , 2015, The American review of respiratory disease.

[98]  L. Findley,et al.  Effect of very-low-calorie diets with weight loss on obstructive sleep apnea. , 1992, The American journal of clinical nutrition.

[99]  V. Somers,et al.  Sympathetic activity in obese subjects with and without obstructive sleep apnea. , 1998, Circulation.

[100]  M. Cosio,et al.  Inspiratory muscle activity as a trigger causing the airways to open in obstructive sleep apnea. , 2015, The American review of respiratory disease.

[101]  P. Ingrand,et al.  Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. , 1994, Chest.

[102]  P. Lloberes,et al.  Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome. , 1998, The European respiratory journal.

[103]  L. Greenfield,et al.  Gastroplasty for Respiratory Insufficiency of Obesity , 1981, Annals of surgery.

[104]  R. Horner Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea. , 1996, Sleep.

[105]  J. Hedner,et al.  Snoring and sleep apnoea in men: association with central obesity and hypertension. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[106]  D. Seals,et al.  Neural mechanisms in human obesity-related hypertension. , 1999, Journal of hypertension.

[107]  S. Harding Prediction formulae for sleep-disordered breathing , 2001, Current opinion in pulmonary medicine.

[108]  M. Kryger,et al.  SLEEP APNOEA PATIENTS HAVE MORE AUTOMOBILE ACCIDENTS , 1987, The Lancet.

[109]  D. Navajas,et al.  Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. , 2001, American journal of respiratory and critical care medicine.

[110]  C Bassetti,et al.  Night time versus daytime transient ischaemic attack and ischaemic stroke: a prospective study of 110 patients , 1999, Journal of neurology, neurosurgery, and psychiatry.

[111]  J. Terán-Santos,et al.  The Association between Sleep Apnea and the Risk of Traffic Accidents , 1999 .

[112]  P. L. Smith,et al.  Leptin prevents respiratory depression in obesity. , 1999, American journal of respiratory and critical care medicine.

[113]  A. J. Block,et al.  Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. , 1982, The American journal of medicine.

[114]  K. Chin,et al.  Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. , 1996, American journal of respiratory and critical care medicine.

[115]  F. Abboud,et al.  Sympathetic neural mechanisms in obstructive sleep apnea. , 1995, The Journal of clinical investigation.

[116]  B. Sanner,et al.  Pulmonary hypertension in patients with obstructive sleep apnea syndrome. , 1997, Archives of internal medicine.

[117]  S. Keenan,et al.  A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. , 1996, Chest.

[118]  P. Suratt,et al.  Fluoroscopic and computed tomographic features of the pharyngeal airway in obstructive sleep apnea. , 2015, The American review of respiratory disease.

[119]  M. Aldrich,et al.  Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. , 1999, Sleep.

[120]  D. Loube,et al.  Continuous positive airway pressure treatment results in weight less in obese and overweight patients with obstructive sleep apnea. , 1997, Journal of the American Dietetic Association.

[121]  E. Onal,et al.  Pathogenesis of apneas in hypersomnia-sleep apnea syndrome. , 1982, The American review of respiratory disease.

[122]  S. Javaheri,et al.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. , 1998, Circulation.

[123]  K. Steinbeck,et al.  The prevalence of obstructive sleep apnoea in an obese female population. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[124]  J. Halverson,et al.  Obstructive sleep apnea in the morbidly obese. An indication for gastric bypass. , 1984, Archives of surgery.

[125]  S A Shea,et al.  Pharyngeal size and shape during wakefulness and sleep in patients with obstructive sleep apnoea. , 1989, The Quarterly journal of medicine.

[126]  J. Stradling,et al.  The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. , 1990, The European respiratory journal.

[127]  G. Mancia,et al.  Sympathetic activation in obese normotensive subjects. , 1995, Hypertension.

[128]  C. Guilleminault,et al.  Power spectral sleep EEG findings in patients with obstructive sleep apnea and upper airway resistance syndromes. , 1999, Electroencephalography and clinical neurophysiology. Supplement.

[129]  O. Resta,et al.  Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects , 2001, International Journal of Obesity.

[130]  S. Mickelson Upper airway bypass surgery for obstructive sleep apnea syndrome. , 1998, Otolaryngologic clinics of North America.

[131]  S. Beske,et al.  Sympathetic Neural Activation in Visceral Obesity , 2002, Circulation.

[132]  R. Gerardi,et al.  Treatment of obese patients with obstructive sleep apnea syndrome (OSAS): effect of weight loss and interference of otorhinolaryngoiatric pathology. , 1990, International journal of obesity.

[133]  J. Dixon,et al.  Sleep disturbance and obesity: changes following surgically induced weight loss. , 2001, Archives of internal medicine.

[134]  P. L. Smith,et al.  Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. , 1991, The American review of respiratory disease.

[135]  S. Kihara,et al.  Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects , 1997, Journal of internal medicine.

[136]  P. L. Smith,et al.  Weight loss in mildly to moderately obese patients with obstructive sleep apnea. , 1985, Annals of internal medicine.

[137]  R. Millman,et al.  Body fat distribution and sleep apnea severity in women. , 1995, Chest.

[138]  P. Lavie,et al.  Sleep Apnea Syndrome in the Morbidly Obese as an Indication for Weight Reduction Surgery , 1984, Annals of surgery.

[139]  S. Redline,et al.  The familial aggregation of obstructive sleep apnea , 1995 .

[140]  S. Redline,et al.  The association between hypertension and sleep apnea in obese patients. , 1993, Chest.

[141]  K. Lam,et al.  Serum leptin and vascular risk factors in obstructive sleep apnea. , 2000, Chest.

[142]  K. Franklin,et al.  Impairment of cerebral perfusion during obstructive sleep apneas. , 1994, American journal of respiratory and critical care medicine.

[143]  S. Javaheri,et al.  Occult Sleep-Disordered Breathing in Stable Congestive Heart Failure , 1995, Annals of Internal Medicine.

[144]  A. Thilmann,et al.  Sleep-disordered breathing among patients with first-ever stroke , 2000, Journal of Neurology.

[145]  Y. Ouchi,et al.  Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. , 2003, Circulation.

[146]  M. Schluchter,et al.  Relation of measures of sleep-disordered breathing to neuropsychological functioning. , 2001, American journal of respiratory and critical care medicine.

[147]  F. Yasuma,et al.  Interaction of chemical and mechanical respiratory stimuli in the arousal response to hypoxia in sleeping dogs. , 1991, The American review of respiratory disease.

[148]  T. Osnes,et al.  The relationship between obstructive sleep apnoea and body mass index. , 1997, Clinical otolaryngology and allied sciences.

[149]  Robert Wolk,et al.  Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea , 2002, Circulation.

[150]  R R Grunstein,et al.  “Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease , 1998, Thorax.

[151]  R. Millman,et al.  Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. , 1993, Chest.

[152]  K R Casey,et al.  Hypopnea in sleep-disordered breathing in adults. , 2001, Sleep.

[153]  J. Piccirillo,et al.  The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. , 1996, Sleep.

[154]  D. Kripke,et al.  Sleep-disordered breathing in community-dwelling elderly. , 1991, Sleep.

[155]  J. Yesavage,et al.  Preliminary communication: intellectual deficit and sleep-related respiratory disturbance in the elderly. , 1985, Sleep.

[156]  J. Hedner,et al.  An independent association between obstructive sleep apnoea and coronary artery disease. , 1999, The European respiratory journal.

[157]  H. Engleman,et al.  Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). , 2003, Sleep medicine reviews.

[158]  K. Strohl,et al.  Insulin levels, blood pressure and sleep apnea. , 1994, Sleep.

[159]  Fleetham Ja Upper airway imaging in relation to obstructive sleep apnea. , 1992 .

[160]  S. Redline,et al.  Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. , 1991, Chest.

[161]  P. Cistulli,et al.  Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. , 1994, The Journal of clinical endocrinology and metabolism.

[162]  R Mathur,et al.  Family Studies in Patients with the Sleep Apnea-Hypopnea Syndrome , 1995, Annals of Internal Medicine.

[163]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[164]  S. Keenan,et al.  The predictive accuracy of home oximetry in patients with suspected obstructive sleep apnea. , 1993, Sleep.

[165]  Crispin Jenkinson,et al.  Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial , 1999, The Lancet.

[166]  G. Richards,et al.  Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. , 1999, Chest.

[167]  A C Bryan,et al.  Upper airway morphology in patients with idiopathic obstructive sleep apnea. , 2015, The American review of respiratory disease.

[168]  D. Rapoport,et al.  Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. , 2001, Chest.

[169]  T. Lasserson,et al.  Drug treatments for obstructive sleep apnoea. , 2001, The Cochrane database of systematic reviews.

[170]  A. Astrup,et al.  The sympathetic nervous system and obesity: role in aetiology and treatment , 2000, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[171]  J. Dixon,et al.  Changes in comorbidities and improvements in quality of life after LAP-BAND placement. , 2002, American journal of surgery.

[172]  P. McLaughlin,et al.  Cardiac output response to continuous positive airway pressure in congestive heart failure. , 1992, The American review of respiratory disease.

[173]  W C Dement,et al.  The sleep apnea syndromes. , 1976, Annual review of medicine.

[174]  P. Cistulli,et al.  A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. , 2001, American journal of respiratory and critical care medicine.

[175]  R. Cartwright Predicting response to the tongue retaining device for sleep apnea syndrome. , 1985, Archives of otolaryngology.

[176]  V. Somers,et al.  Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. , 2000, American journal of physiology. Heart and circulatory physiology.

[177]  J. Stradling,et al.  Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment , 1994, Journal of sleep research.

[178]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[179]  H. Zwick,et al.  Model for investigating snorers with suspected sleep apnoea. , 1993, Thorax.

[180]  J. Pépin,et al.  Deficits of cognitive executive functions in patients with sleep apnea syndrome. , 1995, Sleep.